专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明授权

US09161930B2 Pharmaceutical composition for diabetic nephropathy and its preparation and application 有权
标题翻译：糖尿病肾病药物组合物及其制备及应用
公开(公告)号：US09161930B2
公开(公告)日：2015-10-20
申请号：US13287624
申请日：2011-11-02
申请人： Quan Zhu , Xinghua Shi , Dan Tang , Zhaoguang Zheng , Bao He , Tingting Duan , Fei Gu , Huiquan Cheng , Xiaoling Huang , Yanxia Huang , Rushang Wang
发明人： Quan Zhu , Xinghua Shi , Dan Tang , Zhaoguang Zheng , Bao He , Tingting Duan , Fei Gu , Huiquan Cheng , Xiaoling Huang , Yanxia Huang , Rushang Wang
IPC分类号： A61K31/27 , A61K9/00 , A61K9/20 , A61K9/48
CPC分类号： A61K31/27 , A61K9/0056 , A61K9/2018 , A61K9/2027 , A61K9/2031 , A61K9/2054 , A61K9/2059 , A61K9/4875
摘要： The invention relates to application of 4,4′-diphenylmethane-bis(methyl) carbamates (DPMC) extracted and isolated from Cortex Mori and preparation of medicine for diabetic nephropathy. The pharmaceutical composition is made up of DPMC as active ingredient and the normal drug carriers, and the weight percentage of active ingredient is 0.1-99.5%. For the remarkable effect of prevention and cure for diabetic nephropathy and convenience for use, it will be a new facultative drug for patients.
摘要翻译：本发明涉及从Cortex Mori提取分离的4,4'-二苯基甲烷 - 双（甲基）氨基甲酸酯（DPMC）的应用和糖尿病性肾病药物的制备。药物组合物由作为活性成分的DPMC和正常药物载体组成，活性成分的重量百分比为0.1-99.5％。为了预防和治疗糖尿病肾病和使用便利性的显着效果，它将成为患者的新的兼性药物。

2. 发明申请

US20120053236A1 PHARMACEUTICAL COMPOSITION FOR DIABETIC NEPHROPATHY AND ITS PREPARATION AND APPLICATION 有权
标题翻译：用于糖尿病患者的药物组合物及其制备和应用
公开(公告)号：US20120053236A1
公开(公告)日：2012-03-01
申请号：US13287624
申请日：2011-11-02
申请人： Quan Zhu , Xinghua Shi , Dan Tang , Zhaoguang Zheng , Bao He , Tingting Duan , Fei Gu , Huiquan Cheng , Xiaoling Huang , Yanxia Huang , Rushang Wang
发明人： Quan Zhu , Xinghua Shi , Dan Tang , Zhaoguang Zheng , Bao He , Tingting Duan , Fei Gu , Huiquan Cheng , Xiaoling Huang , Yanxia Huang , Rushang Wang
IPC分类号： A61K31/27 , A61P13/12
CPC分类号： A61K31/27 , A61K9/0056 , A61K9/2018 , A61K9/2027 , A61K9/2031 , A61K9/2054 , A61K9/2059 , A61K9/4875
摘要： The invention relates to application of 4,4′-diphenylmethane-bis(methyl) carbamates (DPMC) extracted and isolated from Cortex Mori and preparation of medicine for diabetic nephropathy. The pharmaceutical composition is made up of DPMC as active ingredient and the normal drug carriers, and the weight percentage of active ingredient is 0.1-99.5%. For the remarkable effect of prevention and cure for diabetic nephropathy and convenience for use, it will be a new facultative drug for patients.
摘要翻译：本发明涉及从Cortex Mori提取分离的4,4'-二苯基甲烷 - 双（甲基）氨基甲酸酯（DPMC）的应用和糖尿病性肾病药物的制备。药物组合物由作为活性成分的DPMC和正常药物载体组成，活性成分的重量百分比为0.1-99.5％。为了预防和治疗糖尿病肾病和使用便利性的显着效果，它将成为患者的新的兼性药物。

3. 发明申请

US20110053872A1 Pharmaceutical Composition For Preventing And Treating Diabetic Nephropathy And The Preparation Method Thereof 审中-公开
标题翻译：用于预防和治疗糖尿病肾病的药物组合物及其制备方法
公开(公告)号：US20110053872A1
公开(公告)日：2011-03-03
申请号：US12810571
申请日：2009-04-01
申请人： Quan Zhu , Xinghua Shi , Dan Tang , Zhaoguang Zheng , Bao He , Tingting Duan , Fei Gu , Huiquan Cheng , Xiaoling Huang , Yanxia Huang , Rushang Wang
发明人： Quan Zhu , Xinghua Shi , Dan Tang , Zhaoguang Zheng , Bao He , Tingting Duan , Fei Gu , Huiquan Cheng , Xiaoling Huang , Yanxia Huang , Rushang Wang
IPC分类号： A61K31/7048 , A61K31/353 , A61P3/10
CPC分类号： A61K31/7048 , A61K31/352
摘要： The present invention relates to a pharmaceutical composition for preventing and treating diabetic complications, mainly referring to diabetic nephropathy, and the pharmaceutical composition comprises one or both of calycosin and calycosin-7-O-β-D-glucoside as 0.1˜99.5% by weight based on the total weight of the composition, and the conventional drug carrier. The pharmaceutical composition could significantly prevent and treat diabetic nephropathy, with the convenience of quality control and administration, which provides a new drug candidate for patients with diabetic nephropathy.
摘要翻译：本发明涉及一种预防和治疗糖尿病并发症的药物组合物，主要涉及糖尿病性肾病，并且该药物组合物包含赤藓糖苷和胡萝卜素-7-O-＆bgr-D-葡萄糖苷之一或两者为0.1〜99.5％基于组合物的总重量和常规药物载体的重量。药物组合物可以显着预防和治疗糖尿病肾病，方便质量控制和给药，为糖尿病肾病患者提供新的候选药物。

4. 发明申请

US20100267819A1 PHARMACEUTICAL COMPOSITION FOR DIABETIC NEPHROPATHY AND ITS PREPARATION AND APPLICATION 审中-公开
标题翻译：用于糖尿病患者的药物组合物及其制备和应用
公开(公告)号：US20100267819A1
公开(公告)日：2010-10-21
申请号：US12823305
申请日：2010-06-25
申请人： QUAN ZHU , Xinghua Shi , Dan Tang , Zhaoguang Zheng , Bao He , Tingting Duan , Fei Gu , Huiquan Cheng , Xiaoling Huang , Yanxia Huang , Rushang Wang
发明人： QUAN ZHU , Xinghua Shi , Dan Tang , Zhaoguang Zheng , Bao He , Tingting Duan , Fei Gu , Huiquan Cheng , Xiaoling Huang , Yanxia Huang , Rushang Wang
IPC分类号： A61K31/352 , C07D311/06 , A61P3/10
CPC分类号： A61K31/353 , A61K9/0056 , A61K9/2018 , A61K9/2027 , A61K9/2031 , A61K9/2054 , A61K9/2059 , A61K9/4875 , A61K31/37
摘要： The invention relates to a pharmaceutical composition for diabetic nephropathy and its preparation, and the application in preparing of medicine for diabetic nephropathy. The pharmaceutical composition is made up of at least one of 7-hydroxycoumarin and 7-hydroxy-6-methoxycoumarin as active ingredient, and the weight percentage of active ingredient is 0.1-99.5%. Moreover, the pharmaceutical composition is mainly used for the prevention and cure of diabetic nephropathy. For the abundant material, remarkable effect on prevention and cure for diabetic nephropathy and convenience for use, it will be a new facultative drug for patients.
摘要翻译：本发明涉及一种糖尿病肾病药物组合物及其制备方法及其在制备糖尿病肾病药物中的应用。药物组合物由7-羟基香豆素和7-羟基-6-甲氧基香豆素中的至少一种作为活性成分组成，活性成分的重量百分比为0.1-99.5％。此外，该药物组合物主要用于预防和治疗糖尿病肾病。对于丰富的材料，对糖尿病肾病的预防和治疗效果显着，使用方便，将成为患者新的兼性药物。

5. 发明申请

US20100261787A1 PHARMACEUTICAL COMPOSITION FOR DIABETIC NEPHROPATHY AND ITS PREPARATION AND APPLICATION 审中-公开
标题翻译：用于糖尿病患者的药物组合物及其制备和应用
公开(公告)号：US20100261787A1
公开(公告)日：2010-10-14
申请号：US12823357
申请日：2010-06-25
申请人： Quan Zhu , Xinghua Shi , Dan Tang , Zhaoguang Zheng , Bao He , Tingting Duan , Fei Gu , Huiquan Cheng , Xiaoling Huang , Yanxia Huang , Rushang Wang
发明人： Quan Zhu , Xinghua Shi , Dan Tang , Zhaoguang Zheng , Bao He , Tingting Duan , Fei Gu , Huiquan Cheng , Xiaoling Huang , Yanxia Huang , Rushang Wang
IPC分类号： A61K31/27 , A61P3/10 , A61P13/12
CPC分类号： A61K31/27 , A61K9/0056 , A61K9/2018 , A61K9/2027 , A61K9/2031 , A61K9/2054 , A61K9/2059 , A61K9/4875
摘要： The invention relates to application of 4,4′-diphenylmethane-bis(methyl)carbamates (DPMC) extracted and isolated from Cortex Mori and preparation of medicine for diabetic nephropathy. The pharmaceutical composition is made up of DPMC as active ingredient and the normal drug carriers, and the weight percentage of active ingredient is 0.1-99.5%. For the remarkable effect of prevention and cure for diabetic nephropathy and convenience for use, it will be a new facultative drug for patients.
摘要翻译：本发明涉及从Cortex Mori提取分离的4,4'-二苯基甲烷 - 双（甲基）氨基甲酸酯（DPMC）的应用和糖尿病性肾病药物的制备。药物组合物由作为活性成分的DPMC和正常药物载体组成，活性成分的重量百分比为0.1-99.5％。为了预防和治疗糖尿病肾病和使用便利性的显着效果，它将成为患者的新的兼性药物。

6. 发明申请

US20070200400A1 Support Structure For Roof Reinforcement 有权
标题翻译：屋顶加固支撑结构
公开(公告)号：US20070200400A1
公开(公告)日：2007-08-30
申请号：US11276326
申请日：2006-02-24
申请人： Dan Tang , James Cheng , Stephen Kozak
发明人： Dan Tang , James Cheng , Stephen Kozak
IPC分类号： B60R21/13 , B60N2/427 , B60N2/48
CPC分类号： B60N2/4242 , B60N2/888
摘要： A support structure comprises a first portion for sliding attachment to a seat having a front, a back, and two sides, and a second portion connected to the first portion at a substantially right angle. The first portion has a hollow cross-sectional shape with an asymmetrical material distribution through the plane of the cross section, the material distribution placing more of the material comprising the first portion toward the sides of the vehicle seat. The support structure is adapted for attachment to the seat and is adapted to be activated to extend in a substantially vertical direction upwardly from the seat. The first portion has an arc shape along its length so that when the support structure is activated the second portion is supported by the first portion at a desirable angle for bracing against an impact force direction that is typical of vehicle rollover.
摘要翻译：支撑结构包括用于滑动地连接到具有前部，后部和两侧的座的第一部分和以大致直角连接到第一部分的第二部分。第一部分具有中空横截面形状，其具有穿过横截面的平面的不对称材料分布，材料分配将包括第一部分的材料的更多部分放置在车辆座椅的侧面。支撑结构适于附接到座椅，并且适于被启动，从座椅向上基本垂直的方向延伸。第一部分沿着其长度具有弧形形状，使得当支撑结构被启动时，第二部分被第一部分以期望的角度支撑，以抵抗典型的车辆翻车的冲击力方向。

7. 外观设计

USD635562S1 Mobile phone 有权
公开(公告)号：USD635562S1
公开(公告)日：2011-04-05
申请号：US29356979
申请日：2010-03-05
申请人： Xue-Song Fan , Tzu-Cheng Yu , Dan Tang
设计人： Xue-Song Fan , Tzu-Cheng Yu , Dan Tang

8. 发明申请

US20090096199A1 REINFORCEMENT FOR A VEHICLE HAVING A PILLARED ROOF 审中-公开
标题翻译：具有立柱屋顶的车辆加固
公开(公告)号：US20090096199A1
公开(公告)日：2009-04-16
申请号：US12339013
申请日：2008-12-18
申请人： Dan Tang
发明人： Dan Tang
IPC分类号： B60R21/13
CPC分类号： B60R21/13 , B60N2/42727 , B60N2/42772 , B60N2/809 , B60N2/888 , B60R2021/135
摘要： A reinforcement for a vehicle having a pillared roof includes a support structure and an activation mechanism to contact the support structure, driving the support structure to an extended position substantially upwardly. The extended support structure is capable of strengthening the pillared roof by contacting the roof to prevent an amount of deformation of the roof during a crash condition causing roof deformation.
摘要翻译：用于具有柱撑屋顶的车辆的加强件包括支撑结构和与支撑结构接触的启动机构，将支撑结构驱动到大致向上的延伸位置。延伸的支撑结构能够通过接触屋顶来加强柱撑的屋顶，以防止在碰撞状态期间屋顶变形的屋顶变形量。

9. 发明授权

US5853487A Process for producing low de starch hydrolysates by nanofiltration fractionation and blending of resultant products, preferably in liquid form, with other carbohydrates 失效
$Process for producing low de starch hydrolysates by nanofiltration fractionation and blending of resultant products, preferably in liquid form, with other carbohydrates$
标题翻译：通过纳滤分级制备低淀粉水解产物的方法，并将所得产物（优选液体形式）与其它碳水化合物
公开(公告)号：US5853487A
公开(公告)日：1998-12-29
申请号：US66651
申请日：1998-04-27
申请人： Dan Tang , Liuming Zhou , Robert Gerhardt
发明人： Dan Tang , Liuming Zhou , Robert Gerhardt
IPC分类号： A23L1/00 , A23L1/09 , A23P1/04 , C08B30/12 , C08B30/18 , C13B20/16 , C13K1/06 , C08B31/00
CPC分类号： C13B20/165 , A23L29/35 , A23P10/30 , C08B30/12 , C08B30/18 , C13K1/06
摘要： A process for producing a substantially non-retrograding starch hydrolysate, involves fractionating a starch hydrolysate comprising a DE greater than about 21 using a nanofiltration membrane, having a molecular weight cut-off of less than about 4,000 daltons, under nanofiltration conditions effective to result in a low DE starch hydrolysate fraction comprising a DE of less than about 25. A process for producing a substantially non-retrograding, low DE starch hydrolysate blend involves combining the product produced by the process of the present invention with a carbohydrate in a predetermined blending ratio to result in a low DE starch hydrolysate blend. A process for hydrogenating a low DE starch hydrolysate fraction produced by the process of the present invention to result in an hydrogenated low DE starch hydrolysate fraction.
摘要翻译：用于生产基本上不退浆的淀粉水解产物的方法包括在纳滤过程条件下，使用分子量截留值小于约4,000道尔顿，使用纳滤膜分级分离大于约21的DE的淀粉水解产物，其有效导致包含小于约25的DE的低DE淀粉水解产物级分。一种用于生产基本上非退化的低DE淀粉水解产物混合物的方法，其包括将本发明方法生产的产物与预定混合比例的碳水化合物以产生低DE淀粉水解产物的混合物。用于氢化由本发明方法生产的低DE淀粉水解产物级分以产生氢化低DE淀粉水解产物级分的方法。

10. 发明授权

US07585023B2 Support structure for roof reinforcement 有权
标题翻译：屋顶加固支撑结构
公开(公告)号：US07585023B2
公开(公告)日：2009-09-08
申请号：US11276326
申请日：2006-02-24
申请人： Dan Tang , James Cheng , Stephen T. Kozak
发明人： Dan Tang , James Cheng , Stephen T. Kozak
IPC分类号： B60N2/427 , B60N2/42 , B60R21/13 , B60R21/00
CPC分类号： B60N2/4242 , B60N2/888
摘要： A support structure comprises a first portion for sliding attachment to a seat having a front, a back, and two sides, and a second portion connected to the first portion at a substantially right angle. The first portion has a hollow cross-sectional shape with an asymmetrical material distribution through the plane of the cross section, the material distribution placing more of the material comprising the first portion toward the sides of the vehicle seat. The support structure is adapted for attachment to the seat and is adapted to be activated to extend in a substantially vertical direction upwardly from the seat. The first portion has an arc shape along its length so that when the support structure is activated the second portion is supported by the first portion at a desirable angle for bracing against an impact force direction that is typical of vehicle rollover.
摘要翻译：支撑结构包括用于滑动地连接到具有前部，后部和两侧的座的第一部分和以大致直角连接到第一部分的第二部分。第一部分具有中空横截面形状，其具有穿过横截面的平面的不对称材料分布，材料分配将包括第一部分的材料的更多部分放置在车辆座椅的侧面。支撑结构适于附接到座椅，并且适于被启动，从座椅向上基本垂直的方向延伸。第一部分沿着其长度具有弧形形状，使得当支撑结构被启动时，第二部分被第一部分以期望的角度支撑，以抵抗典型的车辆翻车的冲击力方向。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式